A federal proposal aims to establish a permanent Medicare drug price negotiation program to lower prescription costs for beneficiaries. The program, created by the Inflation Reduction Act, currently negotiates prices for high-cost drugs, saving billions and reducing out-of-pocket expenses. The new rule would select up to 20 drugs per cycle for negotiation, expanding savings and providing long-term cost certainty for patients and manufacturers.